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Background: Although use of the mechanical ventilator is a life-saving intervention, excessive tidal volumes will
activate NF-κB in the lung with subsequent induction of lung edema formation, neutrophil infiltration and
proinflammatory cytokine/chemokine release. The roles of NF-κB and IL-6 in ventilator-induced lung injury (VILI)
remain widely debated.
Methods: To study the molecular mechanisms of the pathogenesis of VILI, mice with a deletion of IкB kinase in the
myeloid cells (IKKβ△mye), IL-6−/− to WT chimeric mice, and C57BL/6 mice (WT) were placed on a ventilator for 6 hr.
WT mice were also given an IL-6-blocking antibody to examine the role of IL-6 in VILI.
Results: Our results revealed that high tidal volume ventilation induced pulmonary capillary permeability,
neutrophil sequestration, macrophage drifting as well as increased protein in bronchoalveolar lavage fluid (BALF).
IL-6 production and IL-1β, CXCR2, and MIP2 expression were also increased in WT lungs but not in those pretreated
with IL-6-blocking antibodies. Further, ventilator-induced protein concentrations and total cells in BALF, as well as
lung permeability, were all significantly decreased in IKKβ△mye mice as well as in IL6−/− to WT chimeric mice.
Conclusion: Given that IKKβ△mye mice demonstrated a significant decrease in ventilator-induced IL-6 production,
we conclude that NF-κB–IL-6 signaling pathways induce inflammation, contributing to VILI, and IкB kinase in the
myeloid cells mediates ventilator-induced IL-6 production, inflammation, and lung injury.
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Mechanical ventilators (MV) are used to assist ill patients
with respiratory failure to retain normal ventilatory
pumping, pulmonary gas exchange, and avoid alveolar col-
lapse [1]. Longer ventilation time and excessive tidal vol-
ume have been shown to contribute to lung injury [2-4]
and are associated with higher mortality [5]. Human stud-
ies suggest that the release of cytokines/chemokines and
the recruitment of leukocytes causes ventilator-associated
lung injury (VALI) [6]. Experimental models have demon-
strated increased vascular permeability, higher cell count
and protein concentration in the bronchoalveolar lavage
fluid (BALF), and increased inflammatory cell infiltration* Correspondence: chingmei@mail.nsysu.edu.tw; chenlw2001@yahoo.com.tw
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reproduction in any medium, provided the orinto lung tissues in ventilator-induced lung injury (VILI)
[1,2,6-8]. Thus, ventilator stress damages the alveolar bar-
rier and facilitates leukocyte infiltration to promote an in-
flammatory response.
NF-κB, a heterodimer composed of p50/p65, acts as a
nucleoprotein that binds to DNA and regulates the
genes encoding proinflammatory cytokines/chemokines,
adhesion molecules, as well as the regulatory factors in
cell cycle and survival [9,10]. Proteolytic degradation of
IκB that has been phosphorylation by IκB kinase (IKK)
liberates NF-κB to enter the nucleus and activates the
NF-κB-regulated target genes. This process is eventually
terminated through the NF-κB-induced synthesis of IκBs
and, consecutively, cytoplasmic resequestration of this
transcription factor. Previous study has demonstrated
that both hyperoxia and overventilation would activate
NF-κB with subsequent induction of lung edema forma-
tion, neutrophil infiltration and proinflammatory cyto-
kines/chemokines release. Studies also showed that theThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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injury of ventilation [11,12]. The effects of NF-κB activa-
tion in the cellular level under the stimulation of ventila-
tion remain poorly understood.
Interleukin-6 (IL-6) is a pleiotropic cytokine involved
in both pro-inflammatory and anti-inflammatory re-
sponses via regulating leukocyte function and apoptosis
[13]. IL-6 is a protective factor that decreases the injury
produced by the shock model, pulmonary inflammation,
and oxidative damage [8,14,15]. Furthermore, alveolar
barrier disruption and lung permeability can be im-
proved by neutrophil-derived IL-6 in VILI [8]. However,
patients with lower plasma levels of IL-6 were associated
with better outcome [16] and had a lower risk of devel-
oping ventilator-associated pneumonia [17]. Therefore,
the precise role of IL-6 in VILI is still debatable.
Other cytokines produced by bronchial, bronchiolar and
alveolar epithelial cells as well as alveolar macrophages and
neutrophils, have also been shown to be important for
signaling between inflammatory cells and recruiting
leucocytes to the lung [6]. The cytokines IL-1 and TNF-α
activate NF-κB, resulting in transcription of genes ne-
cessary for the innate immune response [6,9]. CXC
chemokines, inter-cellular adhesion molecule (ICAM) and
vascular cell adhesion protein (VCAM), regulated by IL-6
and IL-1, can facilitate neutrophil infiltration [6,13,18], and
MIP-2 is a potent leukocyte chemoattractant [6]. The levels
of proinflammatory cytokines in lung homogenates, serum
and BALF have also been found to be increased after venti-
lation in both clinical and animal models [5,6,19]. The in-
creased production of cytokines/chemokines is critical for
the pathogenesis of VILI and the increased pulmonary vas-
cular leakage that allows leukocytes to enter the tissue
spaces and induces inflammation.
The mechanisms and interactions of IL-6 and NF-κB in
the pathogenesis of VILI are still elusive. We hypothesized
that high stretch ventilation stimulated NF-κB activation
of alveolar macrophages that induced IL-6 and subsequent
IL-1β, CXCR2, as well as MIP2 expression in the lung and
finally the inadvertent activation of inflammation. Using a
high tidal volume ventilation model in mice, we demon-
strate that ventilator-induced IL-6 production and lung
permeability were decreased in IKKβ△mye mice when com-
pared with WT mice. This suggests that nuclear factor-κB
activation in myeloid cell mediates ventilator-induced IL-6
production as well as lung injury. Using a NF-κB inhibitor
to decrease IL-6 production in the lung and subsequent
VILI might be a useful strategy in critical patients.
Methods
Animals
Specific pathogen–free C57BL/6 mice weighing between
20 and 25 g were purchased from the National Labora-
tory Breeding and Research Center (NLBRC, Taipei,Taiwan). Mice genetically deficient for IL-6, (IL-6−/−, in
the C57/BL/6 genetic background) were purchased from
The Jackson Laboratory (Bar Harbor, ME). We obtained
LysM-Cre mice from the Jackson laboratory that express
Cre recombinase from the endogenous Lyzs locus. We
crossed these mice with a strain containing a loxP site
flanking IKKβ previously obtained from Dr. Karin’s lab
at University of California in San Diego. Cre-mediated
recombination results in deletion of the IKKβ gene in
the myeloid cell lineage, including monocytes, mature
macrophages, and granulocytes as previously described
[20]. All purchased animals were maintained in a
temperature and diet controlled room for at least 1 week
before the experiments. All animal procedures were in
compliance with regulations on animals used for experi-
mental and other scientific purposes approved by the
National Sun Yat-Sen University Animal Experiments
Committee.Experimental design
Since ventilation-induced stretch results in lung damage,
we established an animal model to investigate the pos-
sible mechanisms of VILI. WT mice ventilated with low
or high tidal volumes for 6 hr without positive end ex-
piratory pressure (PEEP) were assayed for pulmonary
vascular permeability and neutrophil accumulation. Pul-
monary vascular leakage was quantified by measuring
the extravasation of EBD and lung MPO activity,
representing neutrophil infiltration into the vasculature
and alveoli of the lung. The BALF was also collected to
evaluate the extent of lung damage.
In experiment 1, C57BL/6 (wild-type, WT) mice were
divided into three groups. Group I (control group, n = 6),
received anesthesia, tracheostomy, and endotracheal in-
tubation for six hours. Group II (low tidal volume group,
n = 6), received anesthesia, tracheostomy, and endo-
tracheal intubation with low tidal volume ventilation for
six hours. Group III (high tidal volume group, n = 6), re-
ceived anesthesia, tracheostomy, and endotracheal intub-
ation with high tidal volume ventilation for six hours.
Lung tissues were harvested to assay injury, expression of
proinflammatory cytokines/chemokines, NF-κB DNA-
binding activity, and morphology. Bronchoalveolar lavage
fluid (BALF) was also collected for cell counting and cyto-
kine assay.
In experiment 2, mice with deletion of IкB kinase in
myeloid cells (IKKβ△mye) were divided into two groups.
Group I (control group, n = 6) received anesthesia, trache-
ostomy, and endotracheal intubation for six hours. Group
II (high tidal volume group, n = 6) received anesthesia,
tracheostomy, and endotracheal intubation with high tidal
volume ventilation for six hours. The lung tissues were
harvested and assayed as above.
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tems, Minneapolis, MN) was given (0.25 mg/kg, i.p.) to
WT mice just before ventilator treatment and the effects
of IL-6 blocking was evaluated by the assays described in
experiment 1. C57BL/6 (wild-type, WT) mice were di-
vided into three groups. Group I (control group, n = 6),
received vehicle treatment, anesthesia, tracheostomy,
and endotracheal intubation for six hours. Group II
(high tidal volume group, n = 6), received vehicle treat-
ment, anesthesia, tracheostomy, and endotracheal intub-
ation with high tidal volume ventilation for six hours.
Group III (high tidal volume + IL-6 Ab group, n = 6), re-
ceived IL-6 antibiotic treatment, anesthesia, tracheos-
tomy, and endotracheal intubation with high tidal
volume ventilation for six hours. The lung tissues were
harvested and assayed as above.
In experiment 4, to study whether the myeloid or resi-
dent cells play a critical role in VILI, the bone marrow
cells of WT and IL6−/− mice were harvested and injected
into WT mice respectively to generate the chimeric mice
(WT to WT and IL6−/− to WT mice). Bone marrow-
transplanted chimeras are represented in the format of
bone marrow donor to bone marrow recipient (e.g., IL6−/−
to WT). Six to eight weeks after transplantation, animals
(n = 6 for each group) were subjected to high tidal volume
ventilation treatment and the lung tissues and BALF were
harvested for examination.
Ventilator-induced lung injury in a mouse model
Mice were anaesthetized intraperitoneally with ketamine
(80 mg/kg) and xylazine (10 mg/kg), and the nuchal skin
was cut 1 cm below the mouth. Muscles were separated
and the trachea was exposed and cannulated with 0.7 cm
21G flat syringe needle that connected to a mechanical
ventilator (SAR-830/P, CWE, Pennsylvania, USA) for 6 hr.
During the period of mechanical ventilation, the mice
were given Avertin (15 mg/kg) and supplied with sterile
saline (10 μl/g) every hour. The ventilation strategy was
low stretch (tidal volume = 10 ml/kg) or high stretch (tidal
volume = 30 ml/kg) and without end expiratory pressure
(PEEP). The control mice breathed spontaneously during
this 6-hour period.
Quantification of pulmonary microvascular injury
Ventilation-induced pulmonary microvascular dysfunc-
tion was quantified by measuring the concentration of
Evans Blue Dye (EBD) within the lung after intravenous
injection of the dye. EBD binds avidly to albumin and
has been used as a marker of protein extravasation in
models of inflammatory tissue injury [21]. EBD was
injected (30 mg/kg) into the femoral vein 10 min before
the termination of experiment. The thoracic cavity was
opened and blood samples (0.1 ml each) were taken
from heart after infusion and centrifuged at 2,400 × gfor 7 min to collect the plasma. The pulmonary vascula-
ture was cleared of blood by flushing 3 ml saline through
left ventricular and the lungs were weighed, placed in 1 ml
of formamide and incubated at 37°C for 16 hr. The con-
centrations of EBD extracted from both lung and plasma
were measured at 620 nm. The absorbance at 740 nm was
subtracted from the 620 nm absorbance values to deduct
the contributions from hemoglobin contamination. The
concentration of EBD in lung was normalized by using the
formula: (lung A620/g lung/plasmaA620) [7] and presented
as permeability index.
Pulmonary neutrophil infiltration assay
Lung myeloperoxidase (MPO) activity has been used as
a maker of lung neutrophil infiltration [11]. Mice were
anesthetized and the thorax was opened with median
sternotomy. The bilateral lung and heart were harvested
together, and the pulmonary vasculature was cleared of
blood by gently injecting of 5 ml saline into the right
ventricle. The lung were blotted dry of surface blood
and weighed.
Lung tissues were placed in 50 mM potassium phos-
phate buffer (pH 6.0) with 0.5% hexadecyltrimethylam-
monium bromide and homogenized. The homogenate
was centrifuged at 9500 × g, 4°C for 10 min. An aliquot
(60 μl) of supernatant was added to 939 μl of potassium
phosphate buffer (pH 6.0) with 16.7 mg/ml of O-
dianisidine and 0.5% hydrogen peroxide. The rate of
change in absorbance at 460 nm was measured over 2 min.
One unit of MPO activity was defined as the amount of
enzyme that reduced 1 μmole of peroxide per min and the
data were expressed as units per gram of lung tissue
(Units/g tissue).
Preparation of bronchoalveolar lavage fluid (BALF)
MV is thought to contribute to the monocyte/macro-
phage drift in the tracheobronchial space [7], which can
be measured by analysis of BALF. For whole lung lavage,
the lavage was washed 6 times with 2 separate injections
of 0.5 ml sterile saline through a 21G flat syringe needle
which was cannulated 0.7 cm into the trachea. BALF
collected was used for quantitative cell counting with a
hemocytometer. The BALF was also centrifuged at 350 × g
for 5 min, and the supernatant stored at −80°C for cyto-
kine analysis [6].
Western immunoblots
The harvested lung tissue was weighed and homoge-
nized in protein extraction buffer (Sigma) containing
proteinase inhibitor cocktail (Roche), 1 mM NaF and
1 mM Na3VO4. Homogenized samples (100 μg of pro-
tein each) were subjected to SDS-PAGE at 50 to 80 V
for 3 hr. Proteins were transferred onto a nitrocellulose
membrane and the membrane was blocked with 5%
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150 mM NaCl and 1.2% Tween 20) at room temperature
for 1 hr and incubated with antibody against IL-6, IL-1β,
and ICAM at room temperature for 1 hr. After immuno-
blotting with the specific primary antibodies, membranes
were washed with TBST and incubated with the second-
ary antibody at room temperature for 1 hr. The mem-
branes were washed with TBST and the protein bands
were detected by enhanced chemiluminescence (ECL)
detection reagent (Millipore).
Reverse transcription polymerase chain reaction (RT-PCR)
The total RNAs were extracted from lung tissue and
cells in BALF using the Miniprep Purification Kit
(GeneMark). The cDNAs encoding proinflammatory cy-
tokines/chemokines were generated by reverse transcrip-
tion and amplified by PCR. Sets of IL-6, IL-1β, ICAM,
CXCR2, MIP-2, and GADPH (Glyceraldehyde-3-phos-
phate dehydrogenase) primers were designed according
to those genes documented in GenBank.
For the PCR reaction, to the sterile 0.2 ml tube were
added 3 μl of 10× Gene Taq buffer (Gene Mark Inc. At-
lanta, USA), 2 μl of 2.5 mM dNTP, 0.5 μl of 25 mM
sense and anti-sense primers, and an appropriate
amount of water to make a total volume of 30 μl. After
adding 0.05 μl of Gene Taq DNA polymerase (5U/μl),
amplification was performed in a thermocycler (Bio-
Rad) with the following profile: 5 min at 95°C before the
first cycle, 1 min at 95°C for denaturation, 1 min at 58°C
for annealing, and 1 min 30 sec at 72°C for extension, fi-
nally 10 min at 72°C after the last cycle. The PCR prod-
ucts were separated on 1.5% agarose gel and stained
with ethidium bromide. The approximate size of the
PCR product was obtained by comparing with the
markers (100 bp Ladder, Biolads).
Enzyme-linked immunosorbent assay (ELISA)
The lung tissue, BALF, and supernatant of LPS-
stimulated macrophages were collected for IL-6, IL-1β,
and TNF-α assay by using the mouse ELISA kit
(eBioscience). Tissues were homogenized in lysis buffer
containing 30 mM Tris, pH 7.5, 300 mM NaCl, 2 mM
MgCl2, 10% Triton X-100, 2 mM CaCl2, and 20 μg/ml of
pepstatin A/leupeptin/aprotinin. The homogenate was
centrifuged at 1,000 × g, 4°C for 15 min and the super-
natant was collected for use. The ELISA plates were
coated with 100 μl capture antibody per well at 4°C
overnight. After appropriate wash, 200 μl of assay dilu-
tion buffer was added per well for blocking at room
temperature for 1 hr. The sample and serial dilutions of
standards were added to the plate and incubated at 4°C
overnight. After coating with detection antibody, avidin-
HRP was added and incubated at room temperature for
30 min. The substrate 3,3′,5,5′-tetramethylbenzidine(TMB) was added and incubated for 15 min. Finally, 2 N
H2SO4 was added to stop the reaction and absorbance at
450 nm was measured using an ELISA reader.Electrophoretic mobility shift assay for NF-κB
Tissue nuclear extract was obtained by using NE-PER
nuclear and cytoplasmic extraction reagents (CER I,
CER II and NER, Pierce). Tissue was added 100 μl of
ice-cold CER I containing proteinase inhibitors (0.5 mM
PMSF, 1 mM pepstatinA, 1 mM leupeptin, 1 mM
aprotinin, 1 mM NaF, and 1 mM Na3VO4). Sample was
vortexed vigorously for 15 sec to fully resuspend the tis-
sue and incubated on ice for 10 min. The mixture was
added 11 μl of ice-cold CER II, vortexed for 5 sec, and
incubated on ice for 1 min, then vortexed for 5 sec, and
finally centrifuged at 4°C, 9,500 × g for 7 min. The
supernatant fraction (cytoplasmic extract) was stored
and the insoluble fraction containing nuclei was resus-
pended in 50 μl of NER. The suspension was incubated
on ice and vortexed for 15 sec every 10 min, for a total
of 40 min. Finally the suspension was centrifuged at 4°C,
9,500 × g for 12 min and the supernatant fraction (nu-
clear extract) was immediately transferred to a clean
tube and stored at −80°C until use.
The Bandshift kit (Promega) was used according to
the manufacturer’s instructions. The double-stranded
oligonucleotide DNA probe containing the NF-κB bind-
ing consensus sequence (5′AGTTGAGGGGAC-TTT
CCCAGGC3′) was end-labeled with [γ-32P]ATP (3,000
Ci/mmol at 10 mCi/ml) at 37°C for 10 min using
polynucleotide kinase (5U/μl). To remove the free
radionucleotides, centrifugation with the G-25 microspin
column (Promega) at 600 × g for 5 min was carried out.
The probes were incubated with 5 μg of tissue nuclear
proteins in gel shift binding buffer containing 10 mM
Tris–HCl (pH 7.5), 50 mM NaCl, 1 mM MgCl2, 0.5 mM
DTT, 0.5 mM EDTA, 20% glycerol and 0.5 mg/ml of
poly (dI-dC) to reduce nonspecific binding. Incubations
were carried out at room temperature for 30 min. Reac-
tion mixtures were electrophoresed at 4 °C, 160 V on a
4% nondenaturing polyacrylamide gel and autoradio-
graphed at −80 °C for 12 to 48 hr.Ex vivo alveolar macrophage stimulation
Alveolar macrophages (AM) were harvested from adult
mice by bronchoalveolar lavage (BAL) with Tris-buffered
saline containing 0.25 mM EDTA and EGTA. Cells were
resuspended in RPMI 1640 in a final concentration of
1 × 105 cells/ml. Cells were then cultured in 96-well mi-
crotiter plates for 2 h and washed with RPMI 1640 to re-
move nonadherent cells [22]. Adherent monolayer cells
were stimulated with different doses of LPS (from
Escherichia coli O26:B6 Sigma-Aldrich) or RPMI 1640
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until assayed for TNF-α.Histology
The lung samples were collected and fixed in 4% forma-
lin. The samples were embedded in paraffin, cut into 3–
5 μm sections, and stained with haematoxylin and eosin.
Pulmonary edema and the infiltration of inflammatory
cells were observed.Chimeric mice
Adoptive transfer of myeloid cells using bone marrow
cells has become a well-accepted method for establishing
the contribution of hematopoietic or non-hematopoietic
cells [23]. Bone marrow cells were harvested from femur
and tibia bones of WT or IL-6−/− mice. Recipient ani-
mals were lethally irradiated with 950 cGy using a 137Cs
source twice with a one-hour interval. Bone marrow
cells (at least 1 × 106 cells) were suspended in 100 μl sa-
line and injected into the tail vein of an 8-week-old re-
cipient. The chimeric mice were used for experiments
after 4–6 weeks. To confirm the success of adoptive
transfer, the genotype of bone marrow cells in chimera
was determined after experiments and showed successful
reconstitution (data not shown).Statistics
All data are analyzed by one-way analysis of variance
(ANOVA), followed by Tukey’s Multiple Comparison
Test. All values in the figures and text were expressed as
mean ± standard error of the mean, and P values of less
than 0.05 are considered to be statistically significant.Results
Ventilator induced lung injury in WT mice
WT mice demonstrated a significant increase in pul-
monary vascular permeability (Figure 1A) and MPO ac-
tivity (Figure 1B) after ventilation when compared with
the control group and the extent of the increase was
higher in the high tidal volume group. Also, ventilation
with low and high tidal volume caused 1.2- and 1.8-fold
increases in the total number of cells (Figure 1C) as well
as 1.7- and 3-fold increases in total protein concentra-
tion (Figure 1D) in BALF of mice with low and high tidal
volume ventilator treatment, respectively, when com-
pared with the control group.
The effects of ventilation on lung morphology were
also examined by histological evaluation of tissue sec-
tions. Our data demonstrated that ventilator-induced in-
flammatory cell infiltration, swelling of the parenchyma
as well as alveoli and the extent of cell infiltration were
enhanced with increased tidal volume (Figure 1E).Ventilator induced NF-κB activation and production of
IL-6, IL-1β, and ICAM in the lung
To study the effect of ventilators on NF-κB activation
and IL-6 and IL-1β levels in the lung, lung homogenates
were examined. High tidal volume ventilation induced
23- and 8-fold increases in IL-6 levels in the lung and
BALF, respectively, as compared to the control group
(Figure 2A, 2B). Ventilator-induced IL-6 levels were
much greater than IL-1β levels (Figure 2C, 2D). Notably,
levels of IL-6 were already significantly increased in
BALF in WT mice with low tidal volume ventilation
treatment. The protein levels of IL-6, IL-1β, and ICAM
(Figure 2E) were also increased in WT mice with venti-
lator treatment.
NF-κB is a broad gene transcription regulatory protein
and its activation has been observed in the animal VILI
model. Similar to the cytokine production, DNA binding
activity of NF-κB in the lung was increased in ventilator
treated mice as demonstrated by EMSA. The extent of
NF-κB activation was greater in the high tidal volume
group than the low tidal volume group (Figure 2F).
Ventilators did not induce lung injury in IKKβ△mye mice
Both clinical and experimental studies have revealed that
VILI pathogenesis involves triggering the inadvertent ac-
tivation of inflammation [24]. NF-κB is an important nu-
cleoprotein for the regulation of both the innate and
adaptive immune responses. To evaluate the mechanism
of NF-κB activation in VILI pathogenesis, mice with IкB
kinase deletion in the myeloid cells (IKKβ△mye) were
used. After high-stretch ventilation; the total number of
cells in BALF, total protein in BALF, and pulmonary vas-
cular permeability had significant 20%, 50%, and 40% de-
creases, respectively, (Figure 3A, 3B, 3C) in IKKβ△mye
mice compared to WT mice. However, more neutrophils
were sequestered in the lung of IKKβ△mye mice with ven-
tilator treatment than the WT mice (Figure 3D). This in-
dicates that NF-κB activation in the myeloid cells
decreases ventilator-induced neutrophil infiltration in
the lung.
Decreased alveolar macrophage activity in IKKβ△mye mice
The alveolar macrophages of IKKβ△mye mice showed a
70% decrease in TNF-α production compared to WT
mice when stimulated with high dose LPS (Figure 3E).
NF-κB activation in the myeloid cells is thus important
for the activation of alveolar macrophages.
Ventilator-induced IL-6 production was significantly
decreased in IKKβ△mye mice
The levels of proinflammatory cytokines, IL-6 and IL-1β,
in the lung and BALF of IKKβ△mye mice were also found
to contribute to NF-κB activation in ventilator-induced
Figure 1 Mechanical ventilation induced lung injury. The microvascular permeability was increased in ventilator treated WT mice as assayed
with extravasation Evans Blue dye (A). The increased neutrophil infiltration (B) was demonstrated by increased myeloperoxidase (MPO) activity in
the lung of WT mice with ventilator treatment. Total cell counts (C) and total protein concentration (D) in BALF were increased in WT mice with
ventilator treatment. *P<0.05, **P<0.01, ***P<0.001. (E). The extent of neutrophil infiltration and alveolus swelling was observed in WT mice with
low tidal volume (Low Vt) or high tidal volume (High Vt) ventilator treatment with HE stain.
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creases in ventilation-induced IL-6 levels in the lung and
BALF, respectively, were observed in IKKβ△mye mice
compared to WT mice (Figure 4A, 4B). High tidal vol-
ume ventilator treatment did not alter IL-1β levels in
IKKβ△mye mice (Figure 4C). This indicates that NF-κB
activation in the myeloid cells plays an important role inventilator-induced IL-6 production in the lung and
BALF.
IL-6-blocking antibody treatment decreased
ventilator-induced IL-1β production
Levels of IL-6 in the lung and BALF have been shown to
be significantly increased after ventilator treatment.
Figure 2 The mechanical ventilator (MV) induced the levels of IL-6 and IL-1β in the lung and BALF. MV significantly increased the
production of IL-6 (A, B) and IL-1β (C, D) in the lung and BALF, respectively. *P<0.05, **P<0.01, ***P<0.001. (E) Low tidal volume (Low Vt) or high
tidal volume (High Vt) ventilator treatment induced IL-6, IL-1β, and ICAM protein expression in the lung in WT mice. (F) NF-κB DNA binding
activity of the lung was increased with the strength of ventilation in WT mice. NS=non-specific binding.
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study the role of IL-6 in VILI. Besides the significant de-
crease of IL-6 levels in the lung and BALF (Figure 5A,
5B), injection of IL-6-blocking antibody before high-
stretch ventilation procedure markedly decreased the IL-
1β production in the lung and BALF (Figure 5C, 5D).
Moreover, IL-6-blocking antibody treatment significantly
decreased ventilator-induced IL-1β, CXCR2, and MIP2
mRNA expression in the lung (Figure 5E). This indicates
that specific IL-6-blocking antibody treatment prevents
ventilator-induced IL-1β, CXCR2, and MIP2 expression
in the lung.
IL-6-blocking antibody treatment decreased ventilator-
induced lung injury
Intraperitoneal injection of IL-6-blocking antibodies in
WT mice reversed the effects of ventilation onpulmonary vascular permeability and total number of
cells in BALF (Figure 6A, 6B). Also, IL-6-blocking anti-
body treatment caused significant 15% and 40% de-
creases in pulmonary neutrophil sequestration and total
protein concentration in BALF (Figure 6C, 6D), respect-
ively, when compared to the high tidal volume group.
This indicates that IL-6-blocking antibody treatment de-
creases high tidal volume ventilator-induced lung injury.
IL-6−/− to WT rather than WT to WT chimeric mice showed
a significant decrease in ventilator-induced lung injury
To determine whether IL-6 on the myeloid cells plays a
major role in the ventilator-induced lung injury, we
harvested bone marrow cells from WT and IL-6−/− mice
and injected them into lethally irradiated WT mice re-
spectively to generate WT to WT mice and IL-6−/− to
WT mice. The extent of ventilator-induced pulmonary
Figure 3 Decreased ventilator-induced lung damage in IKKβ△mye mice. High tidal volume ventilation induced total number of cells in BALF
(A), protein concentration in BALF (B), and pulmonary microvascular permeability (C) in WT mice but not in IKKβ△mye mice. However, there was
more neutrophil sequestration in the IKKβ△mye mice (D). *P<0.05, **P<0.01, ***P<0.001. (E). E.coli. LPS stimulation-induced activation of alveolar
macrophages was decreased in IKKβ△mye mice when compared with WT mice.
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total cell count in BALF were all significantly attenuated
in IL6−/− to WT chimeric mice when compared to WT
to WT mice (Figure 7A, 7B, 7C). This indicates that IL-
6 on the myeloid cells plays an important role in high
tidal volume ventilator-induced lung injury.
Discussion
The pathogenesis and molecular mechanisms of
ventilator-associated lung injury remain elusive. Clinicalstudies have shown that additional end-expiratory pres-
sures and lower tidal volume can be protective and pro-
duce a better prognosis [25]. However, in particular
situations, this protective ventilation strategy is insufficient
to improve pulmonary gas exchange in ill patients. The
stretch of ventilation may result in alveolar overdistention,
and subsequently induces barotrauma, volutrauma, and
biotrauma of lung.
In this study, an animal model of VILI was established
and the lung damage was induced in WT mice through
Figure 4 Levels of proinflammatory cytokines in the lung and BALF in IKKβ△mye mice. High tidal volume ventilation-induced IL-6 levels in
the lung (A) and BALF (B) were decreased in IKKβ△mye mice when compared with WT mice. IL-1β levels were assayed in the lung (C) and BALF
(D) of IKKβ△mye mice and WT mice. *P<0.05, **P<0.01.
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ume were examined in WT mice. There were significant
increases in pulmonary microvascular permeability and
neutrophil infiltration in mice after ventilation, indica-
ting that disruption of alveolar barriers can result in
leakage of inflammatory substances and leukocytes. The
increased vascular permeability and neutrophil infiltra-
tion led to pulmonary edema and a decline in lung func-
tion. With VILI progression, the released cytokines/
chemokines promote neutrophil adhesion and sequestra-
tion to the lung [26]. These inflammatory responses
could cause additional lung damage under the stimula-
tion of ventilation. Collection of bronchoalveolar lavage
fluid (BALF) is a common medical procedure to assay
drifting leukocytes and the released proteins in the al-
veolar space, that can be used to diagnose lung diseases.
The BALF was assayed for the total cell counts and pro-
tein concentration to represent the progressive lung
damage with increased tidal volume. The levels of
proinflammatory cytokines IL-6 and IL-1β in BALF of
WT mice with ventilator treatment were higher than in
the control group. Also, both mRNA and protein levelsof the proinflammatory cytokines (IL-6 and IL-1β) and
chemokines (CXCR2 and MIP-2) were increased after
ventilation. In addition, NF-κB, the network hub of im-
munity and inflammation, was also activated after venti-
lator treatment and activated NF-κB can trigger a series
of inflammatory cascades. The extent of VILI was also
observed in the histological morphology showing the
swelling of parenchyma and alveoli as well as altered
cells staining in ventilated WT mice.
To investigate the involvement of NF-κB activation of
myeloid cells in VILI, the IKKβ△mye mice were used. The
pulmonary microvascular permeability, total cell number
and protein concentration in BALF, and alveolar macro-
phage activity were significantly decreased in IKKβ△mye
mice after high-stretch ventilation compared to WT
mice. However, there was more neutrophil infiltration in
the lungs of IKKβ△mye mice. Recently, it had been dem-
onstrated that IKKβ△mye mice would develop neutro-
philia and have higher neutrophil counts in their blood
[27]. Our data further suggest that IKKβ in myeloid cells
plays an important role in inducing the activity of alveo-
lar macrophages and decreasing the ventilator-induced
Figure 5 Mechanical ventilation induced a significant increase of cytokines/chemokines in WT mice but not in IL-6 antibody-treated
WT mice. IL-6 antibody pretreatment decreased high tidal volume ventilation-induced IL-6 levels in the lung (A) and BALF (B) of WT mice. IL-6
antibody pretreatment decreased high tidal volume ventilation-induced IL-1β levels in the lung (C) and BALF (D) of WT mice. *P<0.05, **P<0.01,
***P<0.001. (E) IL-6 antibody treatment decreased high stretch ventilation-induced mRNA expression of proinflammatory cytokines (IL-6, IL-1β)
and chemokines (CXCR2, ICAM, MIP-2) in the lung.
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unchanged IL-1β expression, IKKβ△mye mice with venti-
lator treatment produced markedly decreased levels of
IL-6 in the lung and BALF when compared with WT
mice. Moreover, IL6−/− to WT but not WT to WT
chimeric mice demonstrated a significant decrease in
ventilator-induced lung damage. Altogether, these sug-
gest that VILI depends on NF-κB activation in the mye-
loid cells and subsequent IL-6 production. Inhibition of
NF-κB activation reduces IL-6 production and blocksthe inadvertent inflammation cascade that contributes to
ventilator-induced lung injury.
Although IL-6 was substantially increased among the
proinflammatory substances examined in the ventilator
model, the critical role of this pleiotropic cytokine in
VILI is still controversial. A previous study found that
IL-6 provides a protective effect in hyperoxic acute
lung injury and VILI by reducing mortality, protein
leakage, and endothelial and epithelial membrane injury
through decreasing cell death and DNA fragmentation
Figure 6 Effect of IL-6-blocking antibody pretreatment on high tidal volume ventilation-induced lung damage in WT mice. The
pulmonary microvascular permeability (A), total number of cells in BALF (B), total protein in BALF (C) and neutrophil sequestration (D) in BALF
were determined in WT mice with IL-6-blocking antibody treatment. *P<0.05, **P<0.01, ***P<0.001.
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limited the disruption of alveolar barrier and regulated
neutrophils adhesion and migration [8]. However, ele-
vated IL-6 levels have been observed in most experi-
mental VILI models and IL-6 can be a biological maker
of VALI [6,16]. In this study, the steady increase of
IL-6 levels in the lung and BALF were observed after
ventilation as demonstrated by mRNA or protein de-
tection. To investigate the role of IL-6 in this VILI
model, a specific IL-6-blocking antibody (0.25 mg/kg)
was intraperitoneally injected to WT mice just before
high-stretch ventilation, which had significant thera-
peutic effects in the arthritis [28]. After 6 hr of ventila-
tion procedure, mice pretreated with IL-6-blocking
antibodies showed a decrease in proinflammatory cyto-
kines and adhesion molecules when compared with
high tidal volume group. Besides, blocking IL-6 pro-
duction in VILI had positive effects as demonstrated
by decreased lung damage. This suggests that IL-6production in the lung plays an important role in
ventilator-induced IL-1β, CXCR2, as well as MIP2 pro-
duction and subsequent lung injury. Furthermore,
ventilator-induced pulmonary vascular permeability,
protein concentration as well as total cell count in
BALF were all significantly decreased in IL6−/− to WT but
not in WT to WT chimeric mice. This indicates that IL-6
on the myeloid cells plays an important role in high tidal
volume ventilator-induced lung injury. Moreover, this
further corroborates the finding that ventilator-induced
lung injury through the NF-κB-IL-6 signaling path-
ways in myeloid cells. Using IL-6 or NF-κB inhibitors
could be a useful strategy for decreasing mechanical
ventilation-induced lung injury in respiratory failure
patients.
Conclusions
Mechanical ventilation induces significant increases in
neutrophil accumulation, proinflammatory cytokines in
Figure 7 Decreased ventilator-induced lung damage in IL6−/− to WT chimeric mice but not in WT to WT mice. High tidal volume
ventilation induced pulmonary microvascular permeability (A), protein concentration of BALF (B), and total number of cells in BALF (C) in WT to
WT mice but not in IL6−/− to WT chimeric mice. *P<0.05, **P<0.01, ***P<0.001.
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http://respiratory-research.com/content/14/1/69the lung, total cells as well as protein in BALF, and pul-
monary permeability in WT mice. However, the indica-
tors of lung injury were decreased in WT mice receiving
IL-6-blocking antibodies as well as in IL6−/− to WT
chimeric mice. Also, decreased IL-6 levels and VILI inIKKβ△mye mice suggests that NF-κB activation-induced
IL-6 expression potentially contributes to VILI patho-
genesis. Therefore, NF-κB inhibitors may be useful in
decreasing high tidal volume ventilation-induced IL-6
production and lung injury.
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